Company: PDEX
Filing Date: 2025-05-01
Form Type: 10-Q
Source: 0001079973-25-000729
Chunk: 28

Company: PRO DEX INC
Filing Date: 2025-05-01
Form: 10-Q
Item: Item 8
Chunk 28
---
  
    General and administrative
expenses  
     1,098  
     6% 
     1,012  
     7% 
     3,732  
     8% 
     3,208  
     9% 
     9% 
     16%
  
    Research
and development costs	 
     947  
     5% 
     760  
     5% 
     2,731  
     6% 
     2,353  
     6% 
     25% 
     16%

    $2,158  
     12% 
    $1,789  
     12% 
    $6,674  
     14% 
    $5,640  
     15% 
     21% 
     18%

Selling expenses consist
of salaries and other personnel-related expenses for our business development department, as well as advertising and marketing expenses,
and travel and related costs incurred in generating and maintaining our customer relationships. Selling expenses for the three and nine
months ended March 31, 2025, increased $96,000, or 565%, and $132,000, or 167%, respectively, compared to the corresponding periods of
fiscal 2024. The increase relates primarily to recruiting fees and personnel costs related to our new Director of Business Development
who we hired in December, 2024.

General and administrative
expenses (“G&A”) consist of salaries and other personnel-related expenses of our accounting, finance, facilities, business
systems, and human resource personnel, as well as costs for outsourced information technology services, professional fees, directors’
fees, and other costs and expenses attributable to being a public company. G&A increased $86,000 and $524,000, respectively, during
the three and nine months ended March 31, 2025, when compared to the corresponding periods of the prior fiscal year. The increases relate
primarily to increased bonus accruals, personnel costs, and legal expenses, offset by decreased audit fees and stock compensation expense.

Research and development
costs generally consist of salaries, employer-paid benefits, and other personnel- related costs of our engineering and support personnel,
as well as allocated facility and information technology costs, professional and consulting fees, patent-related fees, lab costs, materials,
and travel and related costs incurred in the development and support of our products